ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,912Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 36

$668K Total Retail Price of All Prescriptions

Rank: 5 out of 36

313 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 313 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

15% of this provider’s 313 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 8,947 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 25.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
WARFARIN SODIUM 775 647 1 5
LEVOTHYROXINE SODIUM 349 319 2 3
DONEPEZIL HCL 326 296 3 9
AMLODIPINE BESYLATE 321 283 4 6
SIMVASTATIN 303 254 5 1
QUETIAPINE FUMARATE 303 260 5 19
FUROSEMIDE 286 257 7 4
MIRTAZAPINE 284 227 8 23
METOPROLOL TARTRATE 235 196 9 8
LISINOPRIL 228 182 10 2
NAMENDA 222 202 11 10
GABAPENTIN 207 162 12 12
HYDROCODONE-ACETAMINOPHEN 188 139 S3 13 11
JANTOVEN 171 163 14 65
OMEPRAZOLE 166 155 15 7
CARVEDILOL 150 139 16 26
BUSPIRONE HCL 129 90 17 63
ESCITALOPRAM OXALATE 120 101 18 28
POLYETHYLENE GLYCOL 3350 117 111 19 32
SERTRALINE HCL 106 45 20 18
LIDODERM 105 99 21 43
LANTUS 93 82 22 27
LEVETIRACETAM 93 62 22 45
KLOR-CON M20 90 85 24 38
SEROQUEL 90 82 24 49
NYSTATIN 90 72 24 73
SANTYL 87 61 27 88
ADVAIR DISKUS 81 70 28 54
TRAZODONE HCL 81 71 28 15
CIPROFLOXACIN HCL 79 66 30 52
TRAMADOL HCL 70 61 31 20
ATORVASTATIN CALCIUM 69 58 32 22
DILTIAZEM 24HR CD 66 51 33 82
ISOSORBIDE MONONITRATE ER 66 55 33 42
BACLOFEN 65 20 35 70
PROMETHAZINE HCL 64 42 R 36 86
ENOXAPARIN SODIUM 63 53 37 177
NOVOLOG 62 59 38 62
TAMSULOSIN HCL 61 58 39 37
HEPARIN SODIUM 61 35 39 180
SODIUM CHLORIDE 60 36 41 130
POTASSIUM CHLORIDE 57 36 42 17
ALBUTEROL SULFATE 57 44 42 51
FAMOTIDINE 57 51 42 39
CLOPIDOGREL 57 47 42 35
DIGOXIN 56 56 46 56
METOPROLOL SUCCINATE 53 53 47 24
OXYBUTYNIN CHLORIDE ER 50 23 48 75
HYDRALAZINE HCL 50 46 48 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.